Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Cowen & Co. Downgrades Apollo Endosurgery to Market Perform, Lowers Price Target to $10

Author: Benzinga Newsdesk | January 23, 2023 08:54am
Cowen & Co. analyst Joshua Jennings downgrades Apollo Endosurgery (NASDAQ:APEN) from Outperform to Market Perform and lowers the price target from $13 to $10.

Posted In: APEN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist